Netzer, Doron

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 1,027

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leshchinsky, M., Ken Dror, S., et al. (2021) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 373

Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

Arbel, R., Peretz, A., Sergienko, R., Friger, M., Beckenstein, T., Duskin-Bitan, H., Yaron, S., Hammerman, A., Bilenko, N., & Netzer, D. (2023) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 145

Evaluation of AI Solutions in Health Care Organizations — The OPTICA Tool

Dagan, N., Devons-Sberro, S., Paz, Z., Zoller, L., Sommer, A., Shaham, G., Shahar, N., Ohana, R., Weinstein, O., Netzer, D., et al. (2024) · NEJM AI

Artificial Intelligence in Healthcare and EducationEthics and Social Impacts of AI

Cited by 27